The Feasibility of Using Bayh-Dole March-In Rights to Lower Drug Prices: An Update
收藏数据链接：
官方服务：
资源简介：
In December 2023, the Biden-Harris Administration released a proposed framework for exercising government march-in rights on high-priced taxpayer-funded drugs. While both proponents and critics of the new rules view them as having broad scope, march-in rights can be exercised only on patents that
提供机构：
美国国家经济研究局创建时间：
2024-03-01
